We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Next-Generation Robotic-Exoscope Delivers Leap Forward in Optical Performance and Robotics to Modernize ORs

By HospiMedica International staff writers
Posted on 04 Dec 2023

A next-generation robotic exoscope is delivering a leap forward in optical performance and robotics to modernize operating rooms. More...

Modus X, the fourth generation of Synaptive Medical’s (Toronto, ON, Canada) robotic exoscope, now comes with redesigned 4K 3D optics, 27x magnification, automated image focus, and voice guidance. Modus X stands out with its capability for fluorescence-guided surgery, which aids in the real-time differentiation of oncological tissues during surgical procedures. Ergonomically designed, Modus X ensures a more comfortable surgical experience, minimizing fatigue. Its enhanced optics and precise robotic positioning are tailored for surgeries involving narrow corridors, facilitating more comprehensive resections while minimizing the need for aggressive tissue retraction. Moreover, Modus X's design is adaptable, allowing for field upgrades from Synaptive’s previous model, Modus V. This flexibility ensures that the 80 hospitals globally already equipped with Modus V can easily transition to the latest technology.

Modus X is a key component of Synaptive’s comprehensive suite of interconnected products, designed to bring together various aspects of surgical intervention – from mid-field MRI and surgical planning to navigation and advanced visualization. Designed through interdisciplinary collaboration to support healthcare professionals and systems, the Synaptive Integrated Suite enables precision care through the synergy of high-quality information and cutting-edge automation at all stages of clinical intervention. The Synaptive Integrated Suite uses powerful technology, including voice control, tool tracking, robotics, and proprietary software, to enhance workflows and deliver unprecedented patient outcomes. Designed to work seamlessly together, but built on an open platform, the Synaptive Integrated Suite of products can integrate with third-party systems to enhance existing workflows.

“We anticipate these enhanced visualization capabilities will enable surgeons to perform even more effective and precise interventions to the benefit of their patients,” said Cameron Piron, President and Co-founder of Synaptive Medical. “Through years of interdisciplinary collaboration with our clinical partners, we have arrived at this ultimate platform that pushes the boundaries of surgical visualization.”

Related Links:
Synaptive Medical


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new AI-based method can predict treatment outcomes from health record data (Photo courtesy of 123RF)

AI Tool Accurately Sorts Cancer Patients by Likely Outcomes

Pharmaceutical companies and healthcare providers often face the challenge of determining which patients will respond most effectively to a given drug. A new artificial intelligence (AI)-based method has... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.